The Ki-67 and Repoman mitotic phosphatases assemble via an identical, yet novel mechanism

Autor: Sofie De Munter, Mathieu Bollen, Ezgi Gokhan, Ganesan Senthil Kumar, Rebecca Page, Paola Vagnarelli, Wolfgang Peti
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Models
Molecular

0301 basic medicine
Magnetic Resonance Spectroscopy
Protein Conformation
Cell Cycle Proteins
Crystallography
X-Ray

0302 clinical medicine
Holoenzymes
Protein Phosphatase 1
structural biology
protein phosphatase 1 (PP1)
Biology (General)
Cancer Biology
Anaphase
General Neuroscience
Nuclear Proteins
General Medicine
Cell cycle
Biophysics and Structural Biology
Chicken
3. Good health
Cell biology
Chromatin
embryonic structures
RepoMan
Ki-67
Medicine
cell cycle
biological phenomena
cell phenomena
and immunity

Human
animal structures
QH301-705.5
Science
Aurora B kinase
macromolecular substances
Biology
General Biochemistry
Genetics and Molecular Biology

03 medical and health sciences
Humans
cancer
Mitosis
General Immunology and Microbiology
E. coli
Protein phosphatase 1
enzymes and coenzymes (carbohydrates)
Ki-67 Antigen
030104 developmental biology
Mitotic exit
Protein Multimerization
Research Advance
Carrier Proteins
030217 neurology & neurosurgery
Zdroj: eLife, Vol 5 (2016)
eLife
Popis: Ki-67 and RepoMan have key roles during mitotic exit. Previously, we showed that Ki-67 organizes the mitotic chromosome periphery and recruits protein phosphatase 1 (PP1) to chromatin at anaphase onset, in a similar manner as RepoMan (Booth et al., 2014). Here we show how Ki-67 and RepoMan form mitotic exit phosphatases by recruiting PP1, how they distinguish between distinct PP1 isoforms and how the assembly of these two holoenzymes are dynamically regulated by Aurora B kinase during mitosis. Unexpectedly, our data also reveal that Ki-67 and RepoMan bind PP1 using an identical, yet novel mechanism, interacting with a PP1 pocket that is engaged only by these two PP1 regulators. These findings not only show how two distinct mitotic exit phosphatases are recruited to their substrates, but also provide immediate opportunities for the design of novel cancer therapeutics that selectively target the Ki-67:PP1 and RepoMan:PP1 holoenzymes. ispartof: Elife vol:5 issue:AUGUST ispartof: location:England status: published
Databáze: OpenAIRE